Cargando…

A Functional 5'-UTR Polymorphism of MYC Contributes to Nasopharyngeal Carcinoma Susceptibility and Chemoradiotherapy Induced Toxicities

MYC is a transcription factor acting as a pivotal regulator of genes involved in cell cycle progression, apoptosis, differentiation and metabolism. In this study, we evaluated the association of MYC polymorphisms with nasopharyngeal carcinoma (NPC) risk and chemoradiotherapy induced toxicities among...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Zhen, Wang, Youhong, Zhao, Yu, Jin, Yi, An, Liang, Xu, Heng, Liu, Zhaoqian, Chen, Xiaoping, Zhou, Honghao, Wang, Hui, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329860/ https://www.ncbi.nlm.nih.gov/pubmed/30662535 http://dx.doi.org/10.7150/jca.28534

Ejemplares similares

Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients
por: Wang, Youhong, et al.
Publicado: (2017)

Author Correction: Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients
por: Wang, Youhong, et al.
Publicado: (2017)

Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients
por: Guo, Zhen, et al.
Publicado: (2017)

Functional polymorphism in the 5′-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma
por: FAN, QIN, et al.
Publicado: (2013)

BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma
por: Wang, Youhong, et al.
Publicado: (2017)

Toxicities of chemoradiotherapy and radiotherapy in nasopharyngeal carcinoma: an updated meta-analysis
por: Wang, Chun, et al.
Publicado: (2019)

Aging increases the susceptibility of cisplatin-induced nephrotoxicity
por: Wen, Jiagen, et al.
Publicado: (2015)

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients
por: Chen, Juan, et al.
Publicado: (2014)

Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients
por: Guo, Zhen, et al.
Publicado: (2022)

3′-UTR Polymorphisms in the Vascular Endothelial Growth Factor Gene (VEGF) Contribute to Susceptibility to Recurrent Pregnancy Loss (RPL)
por: An, Hui Jeong, et al.
Publicado: (2019)

Association of SOX11 Polymorphisms in distal 3′UTR with Susceptibility for Schizophrenia
por: Sun, Cheng‐Peng, et al.
Publicado: (2020)

The Impact of IL-16 3′UTR Polymorphism rs859 on Lung Carcinoma Susceptibility among Chinese Han Individuals
por: Zhuo, Manyun, et al.
Publicado: (2018)

Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
por: Ding, Yuxun, et al.
Publicado: (2021)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Radiotherapy with neoadjuvant chemotherapy versus concurrent chemoradiotherapy for ascending-type nasopharyngeal carcinoma: a retrospective comparison of toxicity and prognosis
por: Yao, Ji-Jin, et al.
Publicado: (2017)

Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma
por: Hou, Jing, et al.
Publicado: (2016)

Hsa-miR-24-3p Increases Nasopharyngeal Carcinoma Radiosensitivity by Targeting Both the 3’UTR and 5’UTR of Jab1/CSN5
por: Wang, Sumei, et al.
Publicado: (2016)

The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N(3) disease
por: Zhang, Yingying, et al.
Publicado: (2017)

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin
por: Liang, Xuexia, et al.
Publicado: (2022)

Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma
por: Chen, Ruijuan, et al.
Publicado: (2021)

CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females
por: Aierken, Kailibinuer, et al.
Publicado: (2019)

KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer
por: Yang, Minnan, et al.
Publicado: (2017)

HLA-G 3’UTR Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients
por: Vaquero-Yuste, Christian, et al.
Publicado: (2021)

Association of Single-Nucleotide Polymorphisms in DC-SIGN with Nasopharyngeal Carcinoma Susceptibility
por: Li, Sisi, et al.
Publicado: (2017)

3’UTR polymorphisms in NRAMP1 are associated with the susceptibility to pulmonary tuberculosis: A MOOSE-compliant meta-analysis
por: Liu, Yang, et al.
Publicado: (2019)

Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis
por: Liu, Zhi-gang, et al.
Publicado: (2016)

Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma
por: Wang, Kailin, et al.
Publicado: (2019)

The efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials
por: Wang, Peirong, et al.
Publicado: (2020)

Induction chemotherapy plus nimotuzumab followed by concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma
por: Song, Xinmao, et al.
Publicado: (2019)

Symptom clusters after chemoradiotherapy in discharged nasopharyngeal carcinoma patients
por: Li, Xiang, et al.
Publicado: (2023)

The clinical prognostic value of PD-L1 after concurrent chemoradiotherapy in Chinese nasopharyngeal carcinoma patients
por: Long, Guoxian, et al.
Publicado: (2021)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zou, Rui, et al.
Publicado: (2021)

Significant Prognostic Impact of Chemoradiotherapy-Induced Hemoglobin Decrease on Treatment Outcomes of Nasopharyngeal Carcinoma
por: Liang, Xue-Xia, et al.
Publicado: (2015)

A variant in SIRT2 gene 3′-UTR is associated with susceptibility to colorectal cancer
por: Yang, Yong, et al.
Publicado: (2017)

ROCK2 Polymorphism and Expression Contribute to Increased Susceptibility and Poor Prognosis in Hepatocellular Carcinoma
por: Qin, Lifeng, et al.
Publicado: (2022)

A Functional TNFAIP2 3'-UTR rs8126 Genetic Polymorphism Contributes to Risk of Esophageal Squamous Cell Carcinoma
por: Zhang, Jian, et al.
Publicado: (2014)

HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis
por: Gan, Jun, et al.
Publicado: (2022)

Combined Ki67 and ERCC1 for prognosis in non-keratinizing nasopharyngeal carcinoma underwent chemoradiotherapy
por: Lu, Ying, et al.
Publicado: (2017)

3′-UTR Polymorphisms of MTHFR and TS Associated with Osteoporotic Vertebral Compression Fracture Susceptibility in Postmenopausal Women
por: Ahn, Tae-Keun, et al.
Publicado: (2018)

The rs4846049 polymorphism in the 3′UTR region of the MTHFR gene increases the migraine susceptibility in an Iranian population
por: Salehi, Mohaddeseh, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_il69smid76kbl4772p4np0s036